When it comes to the use of what is sometimes called "complementary and alternative medicine" (CAM) or, increasingly, "integrative medicine," there is a certain narrative. It's a narrative promoted by CAM proponents that does its best to convince the public that there is nothing unusual, untoward, or odd about CAM use, even though much of CAM consists of treatments that are based on prescientific concepts of human physiology and pathology, such as traditional Chinese medicine or homeopathy.
CARISMA Therapeutics to Present Data at The American Association for Cancer Research Annual Meeting
- First study evaluating CAR-macrophages in fully immunocompetent solid tumor mouse models shows significant tumor control, increased survival, and induction of anti-tumor immunity
- New ultra-rapid, same-day CAR-monocyte manufacturing process may reduce vein-to-vein time
News provided by
Share this article
Share this article
PHILADELPHIA, April 9, 2021 /PRNewswire/ CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced study findings accepted for virtual presentation at The American Association for Cancer Research (AACR) Annual Meeting on Saturday, April 10 – Thursday, April 15. The accepted data reinforces the potential of CARISMA s proprietary chimeric antigen receptor macrophage (CAR-M) platform, as well as the importance of evaluating CAR-monocytes (CAR-Mono) as a novel and exped
Combo Immunotherapy in NSCLC: Not These Two Drugs medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.